Formulation protocol:
1. Piwarski SA, Thompson C, Chaudhry AR, Denvir J, Primerano DA, Fan J, Salisbury TB. The putative endogenous AHR ligand ITE reduces JAG1 and associated NOTCH1 signaling in triple negative breast cancer cells. Biochem Pharmacol. 2020 Apr;174:113845. doi: 10.1016/j.bcp.2020.113845. Epub 2020 Feb 4. PMID: 32032581; PMCID: PMC7418053.
2. Pang LP, Li Y, Zou QY, Zhou C, Lei W, Zheng J, Huang SA. ITE inhibits growth of human pulmonary artery endothelial cells. Exp Lung Res. 2017 Oct;43(8):283-292. doi: 10.1080/01902148.2017.1367868. PMID: 29140133; PMCID: PMC5909382.
3. Seong E, Lee JH, Lim S, Park EH, Kim E, Kim CW, Lee E, Oh GC, Choo EH, Hwang BH, Kim CJ, Ihm SH, Youn HJ, Chung WS, Chang K. Activation of Aryl Hydrocarbon Receptor by ITE Improves Cardiac Function in Mice After Myocardial Infarction. J Am Heart Assoc. 2021 Jul 6;10(13):e020502. doi: 10.1161/JAHA.120.020502. Epub 2021 Jun 23. PMID: 34157850; PMCID: PMC8403290.
4. Abron JD, Singh NP, Mishra MK, Price RL, Nagarkatti M, Nagarkatti PS, Singh UP. An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2018 Aug 1;315(2):G220-G230. doi: 10.1152/ajpgi.00413.2017. Epub 2018 Apr 19. PMID: 29672155; PMCID: PMC6139639.
In vitro protocol:
1. Piwarski SA, Thompson C, Chaudhry AR, Denvir J, Primerano DA, Fan J, Salisbury TB. The putative endogenous AHR ligand ITE reduces JAG1 and associated NOTCH1 signaling in triple negative breast cancer cells. Biochem Pharmacol. 2020 Apr;174:113845. doi: 10.1016/j.bcp.2020.113845. Epub 2020 Feb 4. PMID: 32032581; PMCID: PMC7418053.
2. Pang LP, Li Y, Zou QY, Zhou C, Lei W, Zheng J, Huang SA. ITE inhibits growth of human pulmonary artery endothelial cells. Exp Lung Res. 2017 Oct;43(8):283-292. doi: 10.1080/01902148.2017.1367868. PMID: 29140133; PMCID: PMC5909382.
In vivo protocol:
1. Seong E, Lee JH, Lim S, Park EH, Kim E, Kim CW, Lee E, Oh GC, Choo EH, Hwang BH, Kim CJ, Ihm SH, Youn HJ, Chung WS, Chang K. Activation of Aryl Hydrocarbon Receptor by ITE Improves Cardiac Function in Mice After Myocardial Infarction. J Am Heart Assoc. 2021 Jul 6;10(13):e020502. doi: 10.1161/JAHA.120.020502. Epub 2021 Jun 23. PMID: 34157850; PMCID: PMC8403290.
2. Abron JD, Singh NP, Mishra MK, Price RL, Nagarkatti M, Nagarkatti PS, Singh UP. An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2018 Aug 1;315(2):G220-G230. doi: 10.1152/ajpgi.00413.2017. Epub 2018 Apr 19. PMID: 29672155; PMCID: PMC6139639.